• 31 Jan 22

Poolbeg Pharma sign licence agreement with AnaBio Technologies to develop oral vaccine platform

Poolbeg Pharma sign licence agreement with AnaBio Technologies to develop oral vaccine platform

Poolbeg Pharma PLC | POLB | 4.6 0.25 0.0%

    • 71 views

 

Poolbeg Pharma (Poolbeg Pharma PLC (AIM:POLB)) Jeremy Skillington joins Proactive London to talk about their full licence to develop oral vaccine delivery platform agreed.

The firm has signed a licence agreement with AnaBio Technologies, a specialist micro encapsulation company, to exclusively develop an oral vaccine delivery platform.

He says vaccine uptake is a critical factor in the effectiveness of combating communicable infectious diseases, something that the COVID-19 pandemic has shown in recent months.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Vox Markets Weekly Wrap

Companies: SKLCTLSDGELCOIGPGBGTTGTATETEPORRTRCSASAIEYETETSHOEPXENW7LRBWAOMDCCPALMMPALPOLBATG

Poolbeg Pharma team present option agreement with University College Dublin for melioidosis vaccine

Companies: Poolbeg Pharma PLC

Poolbeg Pharma: Sites ready, data due this summer — and Big Pharma is starting to knock

Companies: Poolbeg Pharma PLC

Poolbeg Pharma - AI Analysis of Human Challenge Data

Companies: Poolbeg Pharma PLC

2026 Could Be a Defining Year for POLB 001 and Oral GLP-1

Companies: Poolbeg Pharma PLC

Q&A: Poolbeg Pharma on target for $1bn cancer opportunity

Companies: Poolbeg Pharma PLC

© Research Tree 2026

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top